(Q54680642)

2 June 2018

title

Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas. (English)

1 reference

2 June 2018

1 reference

9

1 reference

2 June 2018

Zhi Rong Qian

object named as

Zhi Rong Qian

1

0 references

author name string

Toshiaki Sano

2

1 reference

2 June 2018

Katsuhiko Yoshimoto

3

1 reference

2 June 2018

Shozo Yamada

4

1 reference

2 June 2018

Akira Ishizuka

5

1 reference

2 June 2018

Noriko Mizusawa

6

1 reference

2 June 2018

Hidehisa Horiguchi

7

1 reference

2 June 2018

Mitsuyoshi Hirokawa

8

1 reference

2 June 2018

publication date

1 April 2005

1 reference

2 June 2018

published in

Laboratory Investigation

1 reference

2 June 2018

volume

85

1 reference

2 June 2018

issue

4

1 reference

2 June 2018

page(s)

464-473

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.3700248

exact match

0 references

cites work

The pathogenesis of pituitary tumours

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Epigenetic change in pituitary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

CDKN2A/p16 inactivation is related to pituitary adenoma type and size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

COBRA: a sensitive and quantitative DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Emerging molecular markers of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Two genetic hits (more or less) to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Inactivation of p16 in human mammary epithelial cells by CpG island methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

The fundamental role of epigenetic events in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

inferred from DOI database lookup

7 January 2021

based on heuristic

Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700248

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.3700248

1 reference

2 June 2018

PubMed ID

15711568

1 reference

2 June 2018